Ptc Therapeutics (PTCT) Other Non-Current Assets (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Other Non-Current Assets of $21.6 million for Q2 2026, down 0.92% year-over-year from $21.8 million in Q2 2025, and down 4.7% quarter-over-quarter from $22.6 million in Q1 2026.
Ptc Therapeutics (PTCT) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $21.6 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 0.92% year-over-year to $21.6 million; the TTM figure through Jun 2026 stood at $21.6 million (down 0.92% YoY), while the FY2025 annual figure was $18.3 million, down 11.6% from the prior year.
- Other Non-Current Assets for Q2 2026 stood at $21.6 million, down from $22.6 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $60.3 million in Q2 2022, with the low at $18.3 million in Q4 2025.
- The 5-year median for Other Non-Current Assets is $24.9 million (2024), against an average of $32.3 million.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets grew 7.85% in 2023, then slumped 48.73% in 2024.
- Ptc Therapeutics' Other Non-Current Assets stood at $48.6 million in 2022, then decreased by 25.39% to $36.2 million in 2023, then tumbled by 42.88% to $20.7 million in 2024, then fell by 11.6% to $18.3 million in 2025, then advanced by 17.92% to $21.6 million in 2026.
- Business Quant data shows PTCT's Other Non-Current Assets at $21.6 million in Q2 2026, $22.6 million in Q1 2026, and $18.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 21.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.58 Mn |
| Mar 31, 2026 | 22.65 Mn |
| Dec 31, 2025 | 18.30 Mn |
| Sep 30, 2025 | 19.44 Mn |
| Jun 30, 2025 | 21.78 Mn |
| Mar 31, 2025 | 21.42 Mn |
| Dec 31, 2024 | 20.70 Mn |
| Sep 30, 2024 | 25.34 Mn |
| Jun 30, 2024 | 23.10 Mn |
| Mar 31, 2024 | 24.55 Mn |
| Dec 31, 2023 | 36.25 Mn |
| Sep 30, 2023 | 34.74 Mn |
| Jun 30, 2023 | 35.65 Mn |
| Mar 31, 2023 | 47.88 Mn |
| Dec 31, 2022 | 48.58 Mn |
| Sep 30, 2022 | 55.12 Mn |
| Jun 30, 2022 | 60.34 Mn |
| Mar 31, 2022 | 44.40 Mn |
| Dec 31, 2021 | 46.50 Mn |
| Sep 30, 2021 | 65.53 Mn |